Європейський Союз - німецька - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - arthritis, rheumatoide - immunsuppressiva - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Австрія - німецька - AGES (Agentur für Gesundheit und Ernährungssicherheit)

haemato pharm gmbh - amphotericin b -

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

intergal pharma limited (8144431) - daunorubicinhydrochlorid - konzentrat zur herstellung einer infusionslösung - teil 1 - konzentrat zur herstellung einer infusionslösung; daunorubicinhydrochlorid (07163) 53,46 milligramm

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

viiv healthcare b.v. (8182271) - zidovudin - hartkapsel - zidovudin (24191) 100 milligramm

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

viiv healthcare b.v. (8182271) - zidovudin - konzentrat zur herstellung einer infusionslösung - zidovudin (24191) 200 milligramm

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

viiv healthcare b.v. (8182271) - zidovudin - hartkapsel - zidovudin (24191) 250 milligramm

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

viiv healthcare uk limited (8130038) - zidovudin - filmtablette - zidovudin (24191) 300 milligramm

Німеччина - німецька - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

viiv healthcare b.v. (8182271) - zidovudin - lösung zum einnehmen - zidovudin (24191) 50 milligramm

Австрія - німецька - AGES (Agentur für Gesundheit und Ernährungssicherheit)

stada arzneimittel gmbh - tenofovir disoproxil succinat -

Європейський Союз - німецька - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastische mittel - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.